Suzhou Ribo Life Science Co (06938.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenHKD 51.95

From 52W high−38.65%

Volume376000.00

Market capHKD 9.08B

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataSep 18, 2026

Open

HKD 51.95

From 52W high

−38.65%

Volume

376000.00

Market cap

HKD 9.08B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

P/E (TTM)

—

RSI (14)

45.4

MomentumView details →

1D Return

+3.70%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

—

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

—

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

—

ROA (TTM)

—

Asset Turnover

—

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

MomentumView details →

1D Return

+3.70%

YTD Return

—

1Y Return

—

RSI (14)

45.4

vs 50D SMA

−1.28%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

—

Quick Ratio

—

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

HKD 0.02

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

—

Op. CF (TTM)

—

Next earningsMar 25, 2027 →

Latest newsMore news →

Ribo and Madrigal achieved the first candidate drug nomination milestone in their siRNA partnership for MASH therapies.80d ago

Similar companies

GenFleet Therapeutics (Shanghai) Inc.02595.HK Crinetics Pharmaceuticals, Inc.CRNX Abivax S.A.ABVX 中源协和600645.SH ImmunityBio, Inc.IBRX 热景生物688068.SH Find similar companies →

Latest newsMore news →

Ribo and Madrigal achieved the first candidate drug nomination milestone in their siRNA partnership for MASH therapies.80d ago